Joshua Lamstein

Joshua Lamstein

Président chez SCOPUS BIOPHARMA INC.
57 ans
Finance
Technology Services
Health Technology

Profil

Joshua R.
Lamstein
was the founder of 335, Inc., founded in 2010, where the title held was Chief Operating Officer from 2010 to 2012.
Mr. Lamstein is also the founder of The Isosceles Group.
Current positions include Chairman at Scopus Biopharma, Inc. since 2020, Co-Chairman & Managing Partner at Hcfp, Director at True Anthem Corp.
since 2015, Director at Sanctuary, Inc. since 2021, Managing Director at HCFP LLC since 2014, Director at Feed.fm since 2014, Director at Canvs TV since 2015, Trustee at World Education, Inc., and Partner at KEC Ventures since 2014.
Former positions include Co-Chairman at GSP Nutrition, Inc., Director at Penske Media Corp.
from 2013 to 2018, Director at PAVmed, Inc. from 2015 to 2018, Managing Director at GF Capital Management & Advisors LLC from 2008 to 2010, Managing Director at GF Capital Private Equity Management LLC in 2009, Director at Rocksbox, Inc. from 2015 to 2021, Associate at Lehman Brothers, Inc., Associate at Apollo Advisors LP from 1998 to 1999, Partner at LMS Capital Plc from 2000 to 2003, Chief Financial Officer at John Snow, Inc. from 1999 to 2000, Associate at Lehman Brothers Ltd. from 1996 to 1998, General Partner at Briefcam Investments LP from 2012 to 2019, and General Partner at Isoseles Madefire Investors LLC from 2013 to 2019.
Education includes an undergraduate degree from Colgate University conferred in 1991 and a graduate degree from MIT Sloan School of Management conferred in 1996.

Postes actifs de Joshua Lamstein

SociétésPosteDébut
SCOPUS BIOPHARMA INC. Président 01/06/2017
Directeur/Membre du Conseil 01/03/2021
Directeur/Membre du Conseil 01/09/2015
Directeur/Membre du Conseil 01/08/2015
Directeur/Membre du Conseil 01/08/2014
Private Equity Investor 01/06/2014
Private Equity Investor 01/02/2014
Directeur/Membre du Conseil -
Hcfp/Capital Markets LLC
Président -

Anciens postes connus de Joshua Lamstein

SociétésPosteFin
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Joshua Lamstein

Formation de Joshua Lamstein

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Finance

Finance

The Isosceles Group

Technology Services

Health Technology

Consumer Services

Finance

Miscellaneous

Finance

Health Services

Technology Services

Health Services

Health Services

Commercial Services

Finance

Consumer Services

Retail Trade

Finance

Briefcam Investments LP

Technology Services

Finance

Consumer Services

Technology Services

Health Technology

Hcfp/Capital Markets LLC

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Joshua Lamstein